Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Randomized Trial of Low versus Moderate Exposure Busulfan for Infants with Severe Combined Immunodeficiency (SCID) Receiving TCRaB;+/CD19+ Depleted Transplantation: A Phase II Study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC CSIDE Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801
Multiple Cancer Types
Hematologic,
Pediatrics
II
Connelly, James
NCT03619551
VICCNCPED18122